Enterobacteriaceae Sepsis Outcome Programme annual report, 2013
The Australian Group on Antimicrobial Resistance performs regular period-prevalence studies to monitor changes in antimicrobial resistance in selected enteric Gram-negative pathogens. The 2013 survey focussed for the first time on blood stream infections. Four thousand nine hundred and fifty-eight E...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
2014
|
| Online Access: | http://hdl.handle.net/20.500.11937/41357 |
| _version_ | 1848756123353481216 |
|---|---|
| author | Turnidge, J. Gottlieb, T. Mitchell, D. Coombs, Geoffrey Daley, D. Bell, J. |
| author_facet | Turnidge, J. Gottlieb, T. Mitchell, D. Coombs, Geoffrey Daley, D. Bell, J. |
| author_sort | Turnidge, J. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | The Australian Group on Antimicrobial Resistance performs regular period-prevalence studies to monitor changes in antimicrobial resistance in selected enteric Gram-negative pathogens. The 2013 survey focussed for the first time on blood stream infections. Four thousand nine hundred and fifty-eight Enterobacteriaceae species were tested using commercial automated methods (Vitek® 2, BioMérieux; Phoenix™, BD). The results were analysed using Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints (January 2014). Of the key resistances, non-susceptibility to the third-generation cephalosporin, ceftriaxone, was found in 7.5%/7.5% (CLSI/EUCAST criteria respectively) of Escherichia coli; 6.3%/6.3% of Klebsiella pneumoniae, and 7.4%/7.4% of K. oxytoca. Non-susceptibility rates to ciprofloxacin were 10.3%/11.3% for E. coli, 4.6%/7.5% for K. pneumoniae, 0.6%/0.6% for K. oxytoca, and 3.6%/6.1% in Enterobacter cloacae. Resistance rates to piperacillin-tazobactam were 3.1%/6.2%, 4.2%/7.0%, 11.9% /12.6%, and 17.3% /22.2% for the same 4 species respectively. Fourteen isolates were shown to harbour a carbapenemase gene, 9 blaIMP, 3 blaKPC, and 2 blaNDM. |
| first_indexed | 2025-11-14T09:07:12Z |
| format | Journal Article |
| id | curtin-20.500.11937-41357 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T09:07:12Z |
| publishDate | 2014 |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-413572017-01-30T14:50:56Z Enterobacteriaceae Sepsis Outcome Programme annual report, 2013 Turnidge, J. Gottlieb, T. Mitchell, D. Coombs, Geoffrey Daley, D. Bell, J. The Australian Group on Antimicrobial Resistance performs regular period-prevalence studies to monitor changes in antimicrobial resistance in selected enteric Gram-negative pathogens. The 2013 survey focussed for the first time on blood stream infections. Four thousand nine hundred and fifty-eight Enterobacteriaceae species were tested using commercial automated methods (Vitek® 2, BioMérieux; Phoenix™, BD). The results were analysed using Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints (January 2014). Of the key resistances, non-susceptibility to the third-generation cephalosporin, ceftriaxone, was found in 7.5%/7.5% (CLSI/EUCAST criteria respectively) of Escherichia coli; 6.3%/6.3% of Klebsiella pneumoniae, and 7.4%/7.4% of K. oxytoca. Non-susceptibility rates to ciprofloxacin were 10.3%/11.3% for E. coli, 4.6%/7.5% for K. pneumoniae, 0.6%/0.6% for K. oxytoca, and 3.6%/6.1% in Enterobacter cloacae. Resistance rates to piperacillin-tazobactam were 3.1%/6.2%, 4.2%/7.0%, 11.9% /12.6%, and 17.3% /22.2% for the same 4 species respectively. Fourteen isolates were shown to harbour a carbapenemase gene, 9 blaIMP, 3 blaKPC, and 2 blaNDM. 2014 Journal Article http://hdl.handle.net/20.500.11937/41357 restricted |
| spellingShingle | Turnidge, J. Gottlieb, T. Mitchell, D. Coombs, Geoffrey Daley, D. Bell, J. Enterobacteriaceae Sepsis Outcome Programme annual report, 2013 |
| title | Enterobacteriaceae Sepsis Outcome Programme annual report, 2013 |
| title_full | Enterobacteriaceae Sepsis Outcome Programme annual report, 2013 |
| title_fullStr | Enterobacteriaceae Sepsis Outcome Programme annual report, 2013 |
| title_full_unstemmed | Enterobacteriaceae Sepsis Outcome Programme annual report, 2013 |
| title_short | Enterobacteriaceae Sepsis Outcome Programme annual report, 2013 |
| title_sort | enterobacteriaceae sepsis outcome programme annual report, 2013 |
| url | http://hdl.handle.net/20.500.11937/41357 |